J.P. Morgan Notebook: Novavax On US FDA Requests, Takeda’s Strategies For FDA Change

 
• By David Wild and Jessica Merrill
  
Novavax's CEO said its plans remain in place despite the FDA's request for additional COVID-19 vaccine data. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from US FDA